49 research outputs found
In vitro secretion and activity profiles of matrix metalloproteinases, MMP-9 and MMP-2, in human term extra-placental membranes after exposure to Escherichia coli
<p>Abstract</p> <p>Background</p> <p>Premature rupture of fetal membranes (PROM) complicated with intrauterine infection has been associated to alterations of the extracellular matrix (ECM) homeostasis. The aim of this work was to evaluate the integral/functional response of the amnion (AMN) and choriodecidua (CHD) to synthesis, secretion, and activity of MMP-2 and MMP-9 and of their inhibitors TIMP-1, -2, and -4, after stimulation with <it>Escherichia coli</it>.</p> <p>Methods</p> <p>Full-thickness membranes were mounted on a Transwell device, constituting two independent chambers, <it>Escherichia coli </it>(1Ă—10 (6) CFU/mL) were added to either the amniotic or the choriodecidual face or to both. Secretion profiles of MMP-2, MMP-9, TIMP-1, TIMP-2, and TIMP-4 were quantified by ELISA and gelatinolytic activity by zymography. Immunoreactivity for MMP-2 and MMP-9 was revealed by immunohistochemistry and the collagen content was assessed by the hydroxyproline assay.</p> <p>Results</p> <p>Levels of MMP-9 in CHD and AMN increased 4- and 8-fold, respectively, after simultaneous infection. MMP-2 secreted to the medium by CHD increased a mean of 3 times after direct stimulation. Secretion profiles of TIMP-1, TIMP-2, and TIMP-4 remained without significant changes. Collagen content was significantly decreased (4-fold) in infected membranes, and was associated with loss of structural continuity and co-localization with immunoreactive forms of MMP-2 and MMP-9.</p> <p>Conclusions</p> <p>Infection of chorioamniotic membranes with <it>E. coli </it>induces an increase in the secretion of inactive forms and an association to ECM of active forms of MMP-2 and MMP-9 without changes in TIMP-1, -2, and -4. These changes could explain the significant decrease of collagen content and loss of structural continuity.</p
Light and focused ion beam microscopy workflow for resin-embedded tissues
Although the automated image acquisition with the focused ion beam scanning electron microscope (FIB-SEM) provides volume reconstructions, volume analysis of large samples remains challenging. Here, we present a workflow that combines a modified sample protocol of the classical transmission electron microscope with FIB-SEM volume imaging. The proposed workflow enables efficient 3D structural surveys of rabbit ovaries collected at consecutive developmental stages. The precise trimming of the region of interest adds the time dimension to the volume, constructing a virtual 4D electron microscopy. We found filopodia-like processes emitted by oocyte cysts allowing contact between oocytes not previously observed
In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes
<p>Abstract</p> <p>Background</p> <p>Chorioamniotic membranes infection is a pathologic condition in which an abnormal secretion of proinflammatory cytokines halts fetal immune tolerance. The aim of the present study was to evaluate the functional response of human chorioamniotic membranes, as well as the individual contribution of the amnion and choriodecidua after stimulation with Escherichia coli, a pathogen associated with preterm labor.</p> <p>Methods</p> <p>Explants of chorioamniotic membranes from 10 women (37–40 weeks of gestation) were mounted and cultured in a Transwell system, which allowed us to test the amnion and choriodecidua compartments independently. Escherichia coli (1 × 10 6 CFU/mL) was added to either the amniotic or the choriodecidual regions or both; after a 24-h incubation, the secretion of IL-1beta, IL-6, TNFalpha, IL-8, and IL-10 in both compartments was measured using a specific ELISA. Data were analyzed by Kruskal-Wallis one-way analysis of variance.</p> <p>Results</p> <p>After stimulation with Escherichia coli, the choriodecidua compartment showed an increase in the secretion of IL-1beta (21-fold), IL-6 (2-fold), IL-8 (6-fold), and IL-10 (37-fold), regardless of which side of the membrane was stimulated; TNFalpha secretion augmented (22-fold) also but only when the stimulus was applied simultaneously to both sides. When the amnion was stimulated directly, the level of IL-1beta (13-fold) rose significantly; however, the increase in IL-8 secretion was larger (20-fold), regardless of the primary site of infection. TNFalpha secretion in the amnion compartment rose markedly only when Escherichia coli was simultaneously applied to both sides.</p> <p>Conclusion</p> <p>Selective stimulation of fetal membranes with Escherichia coli results in a differential production of IL-1beta, IL-6, TNFalpha, IL-8, and IL-10. These tissues were less responsive when the amnion side was stimulated. This is in agreement with the hypothesis that the choriodecidua may play a primary role during an ascending intrauterine infection, being the main barrier to progression of the infection into the amniotic cavity. Therefore, the tissue-specific capacities for the secretion of these immune modulators could be a determining factor for the degree of severity of the inflammation process in fetal membranes.</p
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis
PURPOSE: Posterior fossa ependymoma comprises two distinct molecular variants termed EPN_PFA and EPN_PFB that have a distinct biology and natural history. The therapeutic value of cytoreductive surgery and radiation therapy for posterior fossa ependymoma after accounting for molecular subgroup is not known. METHODS: Four independent nonoverlapping retrospective cohorts of posterior fossa ependymomas (n = 820) were profiled using genome-wide methylation arrays. Risk stratification models were designed based on known clinical and newly described molecular biomarkers identified by multivariable Cox proportional hazards analyses. RESULTS: Molecular subgroup is a powerful independent predictor of outcome even when accounting for age or treatment regimen. Incompletely resected EPN_PFA ependymomas have a dismal prognosis, with a 5-year progression-free survival ranging from 26.1% to 56.8% across all four cohorts. Although first-line (adjuvant) radiation is clearly beneficial for completely resected EPN_PFA, a substantial proportion of patients with EPN_PFB can be cured with surgery alone, and patients with relapsed EPN_PFB can often be treated successfully with delayed external-beam irradiation. CONCLUSION: The most impactful biomarker for posterior fossa ependymoma is molecular subgroup affiliation, independent of other demographic or treatment variables. However, both EPN_PFA and EPN_PFB still benefit from increased extent of resection, with the survival rates being particularly poor for subtotally resected EPN_PFA, even with adjuvant radiation therapy. Patients with EPN_PFB who undergo gross total resection are at lower risk for relapse and should be considered for inclusion in a randomized clinical trial of observation alone with radiation reserved for those who experience recurrence
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
Posterior fossa ependymoma comprises two distinct molecular variants termed EPN_PFA and EPN_PFB that have a distinct biology and natural history. The therapeutic value of cytoreductive surgery and radiation therapy for posterior fossa ependymoma after accounting for molecular subgroup is not known
Nuevo avance hacia la clonación terapéutica humana: se reaviva la polémica
EstanciasLa clonaciĂłn terapĂ©utica como una opciĂłn para el tratamiento de pacientes con padecimientos genĂ©ticos recibiĂł un nuevo impulso. Un equipo de la Universidad Nacional de SeĂşl, Corea del Sur, generĂł por primera vez una lĂnea de cĂ©lulas troncales derivadas de la masa celular interna de un blastocisto humano. El blastocisto fue desarrollado in vitro a partir de un cigoto “reconstruido” por la fusiĂłn de una cĂ©lula somática del ovario con un ovocito enucleado. De manera que las cĂ©lulas del blastocisto desarrollado poseen copias del genoma de la cĂ©lula somática. Como las cĂ©lulas troncales obtenidas son genĂ©ticamente idĂ©nticas a la cĂ©lula somática, se asume que pudieran ser usadas para transplantarse ya que el rechazo inmunolĂłgico serĂa nulo o muy leve. Si además de cĂ©lulas ováricas usadas por el equipo coreano, se derivan cĂ©lulas troncales clonadas a partir de otras cĂ©lulas de individuos adultos, el camino hacia una clonaciĂłn terapĂ©utica confiable estará abierto. Sin embargo, el manejo de ovocitos humanos “reconstruĂdos” para generar blastocistos plantea cuestiones Ă©ticas porque de ser implantados en el Ăştero de una mujer, podrĂan desarrollarse como individuos clonados. Sin embargo, hay una importante diferencia entre las clonaciones terapĂ©utica y reproductiva en tĂ©rminos de “intencionalidad”. Mientras la primera intenta clonar cĂ©lulas para aliviar a un paciente, en la segunda se busca clonar a un individuo. Como en ambos tipos de clonaciĂłn se requiere del ovocito humano, la discusiĂłn puede centrarse en la potencialidad Ăşnica de esa cĂ©lula para desarrollar a un ser humano. En el presente artĂculo expongo una opiniĂłn al respecto de acuerdo con el actual contexto biolĂłgicoTherapeutic cloning as an alternative clinical method to treat genetic illness has received a new impulse. In South Corea, a team working in the National University of Seul has established for the first time a line of stem cells derived from the inner cell mass of a cloned human blastocyst. The blastocyst developed from a “reconstructed” egg made by fusing an enucleated oocyte with a somatic ovarian cell. Thus, the cells of the developed blastocyst contained copies of the somatic cell genome. Since the derived stem cells are genetically identical to the somatic cell, it is assumed that they can be used for transplantation because the immunological rejection may be null or highly reduced. If besides ovarian somatic cells used by the Corean team, stem cells can also be derived from other adult somatic cells, the way for a reliable therapeutic cloning in humans will be open. However, handling human oocytes “reconstructed” posse ethical concerns since they may develop as a cloned baby if transferred to a woman womb. Thus, distinction between therapeutic and reproductive cloning is in terms of “intentionality”. While the former intends to clone cells of a patient, the latter seeks to clone individuals. Since for both, therapeutic and reproductive cloning human oocytes are required, discussion is centered on the potential of these cells to develop as human beings. In this article a personal opinion is given considering the actual biological contex